Showing results (11-20 of 68) with videos related to
Sort By:
Pageof 7
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 8, 2022
[Comparative Safety Assessment of Ramucirumab plus FOLFIRI and Bevacizumab plus FOLFIRI in Second- and Later-Line Treatment in Japanese Patients with Metastatic Colorectal Carcinoma]Mina Iwai, Michio Kimura, Eiseki Usami, et al.Anticancer Research|February 4, 2019
Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal CancerMichio Kimura, Eiseki Usami, Hitomi Teramachi, et al.Cancer Chemotherapy and Pharmacology|August 14, 2020
Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumabMichio Kimura, Eiseki Usami, Hitomi Teramachi, et al.Anticancer Research|November 29, 2025
Determining Candidate D-dimer Thresholds for Lower-extremity Ultrasound in Monitoring Deep Vein Thrombosis in Patients With Gastric Cancer Receiving RamucirumabShoya Takenaka, Michio Kimura, Mina Iwai, et al.In Vivo (Athens, Greece)|August 28, 2016
Prophylactic Efficacy Against Herpes Zoster and Costs Difference Between Acyclovir and Valaciclovir in Hematological PatientsEiseki Usami, Michio Kimura, Mina Iwai, et al.Medicina (Kaunas, Lithuania)|November 25, 2023
Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report DatabaseHiroki Asano, Yoshihiro Noguchi, Michio Kimura, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 20, 2022
Analysis of adverse events leading to dose reduction/interruption of lenvatinib treatment in patients with Child-Pugh B unresectable hepatocellular carcinomaMichio Kimura, Hiroki Asano, Eiseki Usami, et al.Biomedical Reports|June 28, 2016
Potential drug interaction between paclitaxel and clopidogrelYasutaka Shinoda, Michio Kimura, Eiseki Usami, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2016
[Economic Loss of Remaining Contents in Molecular Target Drug Preparation and the Simulation for Cost Saving]Eiseki Usami, Michio Kimura, Tomohiro Fukuoka, et al.Cancer Diagnosis & Prognosis|May 5, 2025
Factors Influencing Severe Hematologic Toxicity Following Niraparib Therapy in Patients With Ovarian CancerMichio Kimura, Shiori Yamada, Rina Matsuyama, et al.Pageof 7